032 - ARNIs and Entresto - a podcast by Sean P. Kane, PharmD; Khyati Patel, PharmD

In this episode, we discuss the new drug class, ARNI, recently approved for heart failure with a focus on sacubatril/valsartan (Entresto) and the PARADIGM-HF trial.

Further episodes of HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

Further podcasts by Sean P. Kane, PharmD; Khyati Patel, PharmD

Website of Sean P. Kane, PharmD; Khyati Patel, PharmD